SET7 can also be mediated by transient hyperglycemia, triggering H3K4me1 and further activating NF-κB p65 and NF-κB-dependent inflammatory genes in ECs, thus suggesting its critical role in hyperglycemia-mediated vascular complications (105, 122). The gene discussed is SETD7; the disease is Hyperglycemia.